Preventive Vaccine Trends and Forecast
The future of the global preventive vaccine market looks promising with opportunities in the adult and pediatric markets. The global preventive vaccine market is expected to reach an estimated $113.1 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are rising incidence of infectious diseases, growing demand for combination vaccines, and ongoing improvement in vaccine distribution and logistics systems.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Preventive Vaccine by Segment
The study includes a forecast for the global preventive vaccine by type, age group, and region.
Preventive Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Live/Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Subunit Vaccines
• Conjugate Vaccines
• DNA Vaccines
• Recombinant Vector Vaccines
Preventive Vaccine Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• Adults
• Pediatrics
Preventive Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Preventive Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preventive vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preventive vaccine companies profiled in this report include-
• Sanofi
• Pfizer
• Novavax
• Merck
• Johnson & Johnson
Preventive Vaccine Market Insights
Lucintel forecasts that live/attenuated is expected to witness the highest growth over the forecast period.
Within this market, pediatric is expected to witness the higher growth.
North America is expected to witness highest growth over the forecast period.
Features of the Global Preventive Vaccine Market
Market Size Estimates: Preventive vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Preventive vaccine market size by type, age group, and region in terms of value ($B).
Regional Analysis: Preventive vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, age groups, and regions for the preventive vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preventive vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the preventive vaccine market size?
Answer: The global preventive vaccine market is expected to reach an estimated $113.1 billion by 2030.
Q2. What is the growth forecast for preventive vaccine market?
Answer: The global preventive vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the preventive vaccine market?
Answer: The major drivers for this market are rising incidence of infectious diseases, growing demand for combination vaccines, and ongoing improvement in vaccine distribution and logistics systems.
Q4. What are the major segments for preventive vaccine market?
Answer: The future of the preventive vaccine market looks promising with opportunities in the adult and pediatric markets.
Q5. Who are the key preventive vaccine market companies?
Answer: Some of the key preventive vaccine companies are as follows:
• Sanofi
• Pfizer
• Novavax
• Merck
• Johnson & Johnson
Q6. Which preventive vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that live/attenuated is expected to witness the highest growth over the forecast period.
Q7. In preventive vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the preventive vaccine market by type (live/attenuated vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, conjugate vaccines, dna vaccines, and recombinant vector vaccines), age group (adults and pediatrics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Preventive Vaccine Market, Preventive Vaccine Market Size, Preventive Vaccine Market Growth, Preventive Vaccine Market Analysis, Preventive Vaccine Market Report, Preventive Vaccine Market Share, Preventive Vaccine Market Trends, Preventive Vaccine Market Forecast, Preventive Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.